๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacology and Treatment Seborrhoeic dermatitis and Pityrosporumorbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone

โœ Scribed by J. FAERGEMANN

Book ID
108659575
Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
346 KB
Volume
114
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Randomized comparison of the type 4 phos
Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis
โœ C.E.M. Griffiths; E.J.M. Van Leent; M. Gilbert; J. Traulsen ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 301 KB

## Background: Therapeutic options to treat atopic dermatitis are limited. leukocytes from atopic patients have an abnormally high activity of cyclic adenosine monophosphate (amp)-phosphodiesterase (pde), which can be normalized in vitro by pde inhibitors. cipamfylline is a new potent and selective

Efficacy, cutaneous tolerance and cosmet
Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowenยฎ) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis
โœ Susanne Freeman; Anne Howard; Peter Foley; Robert Rosen; Glenda Wood; Jo-Ann See ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 133 KB

## SUMMARY The differences between topical corticosteroids are based mainly on their potency, safety and patient acceptability. The aim of this study was to evaluate a mildโ€ to midโ€potent topical corticosteroid, desonide 0.05%, on these three parameters in an Australian cohort of patients with faci